Thanks for the update Tada. I have not really given rvx a moments thought since the last webcast. More hot air or another red herring to lure in more unsuspecting investors?
Question I have is how will this give value? will this really have a place in the market with the plethora of vaccines coming if successful or would it just be a purely academic victory but no real monetary value? In other words more of the same ugh!
CCD